Avidity Partners Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,053,300	Closed	-$13.2M	–	84
2024 Q4	$13.2M	Buy	1,053,300 +304,300	+41%	+$4.58M	1.32%	34
2024 Q3	$13.8M	Sell	749,000 -351,000	-32%	-$7.19M	0.71%	53
2024 Q2	$23.7M	Buy	1,100,000 +75,000	+7%	+$1.72M	1.01%	43
2024 Q1	$27.6M	Sell	1,025,000 -694,103	-40%	-$19.7M	0.98%	40
2023 Q4	$51.5M	Buy	1,719,103 +131,674	+8%	+$2.91M	1.97%	20
2023 Q3	$32.5M	Buy	1,587,429 +261,429	+20%	+$4.75M	1.31%	36
2023 Q2	$26.3M	Buy	1,326,000 +81,600	+7%	+$1.65M	0.92%	45
2023 Q1	$21.3M	Sell	1,244,400 -282,687	-19%	-$5.54M	0.71%	45
2022 Q4	$29.9M	Buy	+1,527,087	New	+$28.1M	0.7%	44
2021 Q1	–	Sell	-50,000	Closed	-$2.74M	–	120
2020 Q4	$2.74M	Buy	+50,000	New	+$1.82M	0.09%	89
2020 Q1	–	Sell	-30,000	Closed	-$683K	–	63
2019 Q4	$683K	Buy	+30,000	New	+$501K	0.43%	30